137 related articles for article (PubMed ID: 23074909)
1. Cytotoxicity analysis of active components in bitter melon (Momordica charantia) seed extracts using human embryonic kidney and colon tumor cells.
Chipps ES; Jayini R; Ando S; Protzman AD; Muhi MZ; Mottaleb MA; Malkawi A; Islam MR
Nat Prod Commun; 2012 Sep; 7(9):1203-8. PubMed ID: 23074909
[TBL] [Abstract][Full Text] [Related]
2. Extraction, quantification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia) harvested at three maturity stages (immature, mature, and ripe).
Horax R; Hettiarachchy N; Chen P
J Agric Food Chem; 2010 Apr; 58(7):4428-33. PubMed ID: 20225855
[TBL] [Abstract][Full Text] [Related]
3. Alpha-eleostearic acid and its dihydroxy derivative are major apoptosis-inducing components of bitter gourd.
Kobori M; Ohnishi-Kameyama M; Akimoto Y; Yukizaki C; Yoshida M
J Agric Food Chem; 2008 Nov; 56(22):10515-20. PubMed ID: 18959405
[TBL] [Abstract][Full Text] [Related]
4. Bitter melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis.
Ray RB; Raychoudhuri A; Steele R; Nerurkar P
Cancer Res; 2010 Mar; 70(5):1925-31. PubMed ID: 20179194
[TBL] [Abstract][Full Text] [Related]
5. Promise of bitter melon (Momordica charantia) bioactives in cancer prevention and therapy.
Raina K; Kumar D; Agarwal R
Semin Cancer Biol; 2016 Oct; 40-41():116-129. PubMed ID: 27452666
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant properties and quantitative UPLC-MS analysis of phenolic compounds from extracts of fenugreek (Trigonella foenum-graecum) seeds and bitter melon (Momordica charantia) fruit.
Kenny O; Smyth TJ; Hewage CM; Brunton NP
Food Chem; 2013 Dec; 141(4):4295-302. PubMed ID: 23993618
[TBL] [Abstract][Full Text] [Related]
7. Extraction, fractionation and characterization of bitter melon seed proteins.
Horax R; Hettiarachchy N; Over K; Chen P; Gbur E
J Agric Food Chem; 2010 Feb; 58(3):1892-7. PubMed ID: 20052973
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of P-glycoprotein activity and reversal of cancer multidrug resistance by Momordica charantia extract.
Limtrakul P; Khantamat O; Pintha K
Cancer Chemother Pharmacol; 2004 Dec; 54(6):525-30. PubMed ID: 15248030
[TBL] [Abstract][Full Text] [Related]
9. Momordica charantia extract on insulin resistance and the skeletal muscle GLUT4 protein in fructose-fed rats.
Shih CC; Lin CH; Lin WL; Wu JB
J Ethnopharmacol; 2009 May; 123(1):82-90. PubMed ID: 19429344
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial activity and agricultural properties of bitter melon (Momordica charantia L.) grown in northern parts of Turkey: a case study for adaptation.
Yaldız G; Sekeroglu N; Kulak M; Demirkol G
Nat Prod Res; 2015; 29(6):543-5. PubMed ID: 25141891
[TBL] [Abstract][Full Text] [Related]
11. Bitter melon (Momordica charantia) extract suppresses adrenocortical cancer cell proliferation through modulation of the apoptotic pathway, steroidogenesis, and insulin-like growth factor type 1 receptor/RAC-α serine/threonine-protein kinase signaling.
Brennan VC; Wang CM; Yang WH
J Med Food; 2012 Apr; 15(4):325-34. PubMed ID: 22191569
[TBL] [Abstract][Full Text] [Related]
12. Bitter Melon (Momordica charantia) Extract Inhibits Tumorigenicity and Overcomes Cisplatin-Resistance in Ovarian Cancer Cells Through Targeting AMPK Signaling Cascade.
Yung MM; Ross FA; Hardie DG; Leung TH; Zhan J; Ngan HY; Chan DW
Integr Cancer Ther; 2016 Sep; 15(3):376-89. PubMed ID: 26487740
[TBL] [Abstract][Full Text] [Related]
13. RNase MC2: a new Momordica charantia ribonuclease that induces apoptosis in breast cancer cells associated with activation of MAPKs and induction of caspase pathways.
Fang EF; Zhang CZ; Fong WP; Ng TB
Apoptosis; 2012 Apr; 17(4):377-87. PubMed ID: 22134530
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chemopreventive and cytotoxic effect of lemon seed extracts on human breast cancer (MCF-7) cells.
Kim J; Jayaprakasha GK; Uckoo RM; Patil BS
Food Chem Toxicol; 2012 Feb; 50(2):423-30. PubMed ID: 22056335
[TBL] [Abstract][Full Text] [Related]
15. BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells.
Dia VP; Krishnan HB
Sci Rep; 2016 Sep; 6():33532. PubMed ID: 27628414
[TBL] [Abstract][Full Text] [Related]
16. Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats.
Sathishsekar D; Subramanian S
Asia Pac J Clin Nutr; 2005; 14(2):153-8. PubMed ID: 15927932
[TBL] [Abstract][Full Text] [Related]
17. Immunoaffinity purification of α-momorcharin from bitter melon seeds (Momordica charantia).
Yao X; Li J; Deng N; Wang S; Meng Y; Shen F
J Sep Sci; 2011 Nov; 34(21):3092-8. PubMed ID: 21994203
[TBL] [Abstract][Full Text] [Related]
18. The effects of bitter melon (Momordica charantia) on serum and liver triglyceride levels in rats.
Senanayake GV; Maruyama M; Shibuya K; Sakono M; Fukuda N; Morishita T; Yukizaki C; Kawano M; Ohta H
J Ethnopharmacol; 2004 Apr; 91(2-3):257-62. PubMed ID: 15120448
[TBL] [Abstract][Full Text] [Related]
19. Influence of pomegranate seed oil and bitter melon aqueous extract on polyunsaturated fatty acids and their lipoxygenase metabolites concentration in serum of rats.
Białek A; Jelińska M; Tokarz A; Pergół A; Pinkiewicz K
Prostaglandins Other Lipid Mediat; 2016 Nov; 126():29-37. PubMed ID: 27418544
[TBL] [Abstract][Full Text] [Related]
20. Bitter melon: a panacea for inflammation and cancer.
Dandawate PR; Subramaniam D; Padhye SB; Anant S
Chin J Nat Med; 2016 Feb; 14(2):81-100. PubMed ID: 26968675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
